-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At the turn of the new year, the pharmaceutical industry is on the rise again
.
First, it was reported on the Internet that Chinese pharmaceutical companies were included in the restricted list by the United States, and the road to internationalization was blocked, resulting in a plunge in all sectors related to innovative drugs
.
Subsequently, the domestic test data of a well-known pharmaceutical company was questioned by the FDA, which caused concern in the industry
.
Then, in the craze for oral new crown drug research and development, the results of a clinical phase III clinical trial of a well-known biotech company in China failed to meet expectations, which once again deepened the market's panic about innovative drugs
.
.
First, it was reported on the Internet that Chinese pharmaceutical companies were included in the restricted list by the United States, and the road to internationalization was blocked, resulting in a plunge in all sectors related to innovative drugs
.
Subsequently, the domestic test data of a well-known pharmaceutical company was questioned by the FDA, which caused concern in the industry
.
Then, in the craze for oral new crown drug research and development, the results of a clinical phase III clinical trial of a well-known biotech company in China failed to meet expectations, which once again deepened the market's panic about innovative drugs
.
Funds are looking for safe havens, and the traditional Chinese medicine sector, which has been tepid for many years, has become a fragrant pastry overnight
.
For a time, various brokerages and various media said that Chinese medicine must be said
.
Immediately afterwards, the National Medical Insurance Administration and the Administration of Traditional Chinese Medicine issued the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine" (hereinafter referred to as the "Guiding Opinions")
.
Delighted with such divine assistance, traditional Chinese medicine can be described as "every time, heaven and earth all work together"
.
On January 4, the first trading day of the new year, 20% of A-share Chinese medicine stocks hit the daily limit! However, the traditional Chinese medicine sector was pulled back the next day
.
.
For a time, various brokerages and various media said that Chinese medicine must be said
.
Immediately afterwards, the National Medical Insurance Administration and the Administration of Traditional Chinese Medicine issued the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine" (hereinafter referred to as the "Guiding Opinions")
.
Delighted with such divine assistance, traditional Chinese medicine can be described as "every time, heaven and earth all work together"
.
On January 4, the first trading day of the new year, 20% of A-share Chinese medicine stocks hit the daily limit! However, the traditional Chinese medicine sector was pulled back the next day
.
Mr.
Piao once said that "business management can't stare at the stock price every day", so how should traditional Chinese medicine be developed as a traditional cultural treasure of the motherland? In recent years, the state has issued many policies in the field of traditional Chinese medicine, and continued to increase support and investment, which contains thinking and guidance on the future development path of traditional Chinese medicine
.
Piao once said that "business management can't stare at the stock price every day", so how should traditional Chinese medicine be developed as a traditional cultural treasure of the motherland? In recent years, the state has issued many policies in the field of traditional Chinese medicine, and continued to increase support and investment, which contains thinking and guidance on the future development path of traditional Chinese medicine
.
Figure 1.
Major policies of the Chinese medicine industry in recent years
Major policies of the Chinese medicine industry in recent years
Source: Government website, Zhongkang Industrial Capital Research Center
Strengthen medical insurance support
On December 30, 2021, the "Guiding Opinions" jointly issued by the National Medical Insurance Administration and the Administration of Traditional Chinese Medicine promoted the reform of traditional Chinese medicine from the aspects of terminal coverage, pricing system, and payment system
.
Previously, some policies started from the top-level design, which was a little rhetorical but unrealistic, and this document has unprecedented benefits for the implementation of traditional Chinese medicine
.
.
Previously, some policies started from the top-level design, which was a little rhetorical but unrealistic, and this document has unprecedented benefits for the implementation of traditional Chinese medicine
.
Figure 2.
Core content of the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine"
Core content of the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine"
Source: State Administration of Traditional Chinese Medicine website, Zhongkang Industrial Capital Research Center
From the core content of the "Guiding Opinions", it can be seen that traditional Chinese medicine medical services benefit the most from it.
The positive factors include: the inclusion of more terminals in medical insurance; the dynamic adjustment of prices makes the service possible to increase the price; the 25% markup of decoction pieces is reserved, and the decoction pieces in the hospital and The independent pricing of preparations and the transparency of the price of formula granules have a positive impact on the drug revenue of traditional Chinese medicine services; it is clear that the temporary absence of DRG payment can increase the amount of traditional Chinese medicine prescriptions
.
This results relative to the zero addition, the implementation of DRG payment of generics and innovative drugs, medical institutions is clearly more popular with a good variety of traditional Chinese medicine, traditional Chinese medicine prescriptions for enhancing the use of scenarios under medical institutions and some OTC sale of Chinese medicine has a certain significance
.
The positive factors include: the inclusion of more terminals in medical insurance; the dynamic adjustment of prices makes the service possible to increase the price; the 25% markup of decoction pieces is reserved, and the decoction pieces in the hospital and The independent pricing of preparations and the transparency of the price of formula granules have a positive impact on the drug revenue of traditional Chinese medicine services; it is clear that the temporary absence of DRG payment can increase the amount of traditional Chinese medicine prescriptions
.
This results relative to the zero addition, the implementation of DRG payment of generics and innovative drugs, medical institutions is clearly more popular with a good variety of traditional Chinese medicine, traditional Chinese medicine prescriptions for enhancing the use of scenarios under medical institutions and some OTC sale of Chinese medicine has a certain significance
.
The "Guiding Opinions" encourages the inclusion of traditional Chinese medicine formula granules purchased by public medical institutions into provincial-level centralized pharmaceutical procurement platforms for online transactions to promote open and transparent transactions
.
The gradual standardization of the national market medical insurance payment standard for formula granules will break the exclusive advantage of medical insurance reimbursement of provincial pilot enterprises under local protection , which is conducive to the orderly development of the market
.
In February 2022, the State Food and Drug Administration and other four departments jointly issued the "Announcement on Ending the Pilot Work of TCM Formula Granules", and the switching of implementation standards in the future will bring opportunities for the price increase of TCM formula granules
.
In addition, after the implementation of the new national standard, there may be a nationwide centralized procurement, which will increase the substitution rate of formula granules for decoction pieces, and the exchange of price for quantity is expected to bring growth to related enterprises
.
.
The gradual standardization of the national market medical insurance payment standard for formula granules will break the exclusive advantage of medical insurance reimbursement of provincial pilot enterprises under local protection , which is conducive to the orderly development of the market
.
In February 2022, the State Food and Drug Administration and other four departments jointly issued the "Announcement on Ending the Pilot Work of TCM Formula Granules", and the switching of implementation standards in the future will bring opportunities for the price increase of TCM formula granules
.
In addition, after the implementation of the new national standard, there may be a nationwide centralized procurement, which will increase the substitution rate of formula granules for decoction pieces, and the exchange of price for quantity is expected to bring growth to related enterprises
.
Accelerate Chinese Medicine Development Features
On February 9, 2021, the General Office of the State Council issued the "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Characteristics" (hereinafter referred to as "Policy Measures"), which aims to give full play to the characteristics and comparative advantages of traditional Chinese medicine and promote the mutual complementation of traditional Chinese medicine and Western medicine.
, Coordinated development
.
This document includes 28 policies and measures, covering 7 major aspects: consolidate the talent base of traditional Chinese medicine, improve the development vitality of the traditional Chinese medicine industry, enhance the development momentum of traditional Chinese medicine, improve the system of integrated traditional Chinese and western medicine, implement major projects for the development of traditional Chinese medicine, improve the development efficiency of traditional Chinese medicine, Create a favorable environment for the development of traditional Chinese medicine
.
, Coordinated development
.
This document includes 28 policies and measures, covering 7 major aspects: consolidate the talent base of traditional Chinese medicine, improve the development vitality of the traditional Chinese medicine industry, enhance the development momentum of traditional Chinese medicine, improve the system of integrated traditional Chinese and western medicine, implement major projects for the development of traditional Chinese medicine, improve the development efficiency of traditional Chinese medicine, Create a favorable environment for the development of traditional Chinese medicine
.
Figure 3.
Main content of "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Characteristics"
Main content of "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Characteristics"
Source: National government website, Zhongkang Industrial Capital Research Center
In terms of promoting the high-quality development of the traditional Chinese medicine industry, the first is to optimize the management of the review and approval of traditional Chinese medicines, and the second is to improve the management of the classification and registration of traditional Chinese medicines
.
The "Policy Measures" pointed out that it is necessary to strengthen the horizontal linkage of departments, and establish an effective mechanism for the departments of science and technology, medical care, and traditional Chinese medicine to recommend new traditional Chinese medicines to enter the fast-track review and approval channel
.
The document also points out that it is necessary to improve the registration classification and application requirements of traditional Chinese medicine, and exempt non-clinical safety research and some clinical trials for eligible innovative traditional Chinese medicine drugs, new improved traditional Chinese medicine drugs, ancient classic prescriptions, and drugs with the same name and same name
.
Make full use of data science and other technical means to establish a "three-in-one" Chinese medicine registration review evidence system of traditional Chinese medicine theory, human experience, and clinical trials, and explore the establishment of a real-world research evidence system for traditional Chinese medicine
.
.
The "Policy Measures" pointed out that it is necessary to strengthen the horizontal linkage of departments, and establish an effective mechanism for the departments of science and technology, medical care, and traditional Chinese medicine to recommend new traditional Chinese medicines to enter the fast-track review and approval channel
.
The document also points out that it is necessary to improve the registration classification and application requirements of traditional Chinese medicine, and exempt non-clinical safety research and some clinical trials for eligible innovative traditional Chinese medicine drugs, new improved traditional Chinese medicine drugs, ancient classic prescriptions, and drugs with the same name and same name
.
Make full use of data science and other technical means to establish a "three-in-one" Chinese medicine registration review evidence system of traditional Chinese medicine theory, human experience, and clinical trials, and explore the establishment of a real-world research evidence system for traditional Chinese medicine
.
The "Policy Measures" further accelerated the review and approval of new Chinese medicines.
From 2017 to 2021, a total of 20 new Chinese medicines were approved for marketing, of which as many as 12 in 2021
.
From the perspective of therapeutic areas, there are many drugs related to endocrine system and metabolic diseases, circulatory system diseases, musculoskeletal system diseases, and respiratory system diseases
.
New traditional Chinese medicine drugs can be included in the national medical insurance through normalized negotiation, and the volume can be quickly realized
.
Judging from the price drop of new drugs in the medical insurance negotiation in 2020, the average price drop of Chinese patent medicines is 37%, which is smaller than the average drop of 63% for western medicines
.
From 2017 to 2021, a total of 20 new Chinese medicines were approved for marketing, of which as many as 12 in 2021
.
From the perspective of therapeutic areas, there are many drugs related to endocrine system and metabolic diseases, circulatory system diseases, musculoskeletal system diseases, and respiratory system diseases
.
New traditional Chinese medicine drugs can be included in the national medical insurance through normalized negotiation, and the volume can be quickly realized
.
Judging from the price drop of new drugs in the medical insurance negotiation in 2020, the average price drop of Chinese patent medicines is 37%, which is smaller than the average drop of 63% for western medicines
.
Figure 4.
New Chinese medicines approved for marketing in China in 2021
New Chinese medicines approved for marketing in China in 2021
Source: State Food and Drug Administration, Zhongkang Industrial Capital Research Center
Chinese medicine industry is expected to continue to prosper
Compared with Western medicine, traditional Chinese medicine has unique advantages in specific therapeutic areas, and it is mainly complementary and synergistic development with innovative drugs and generic drugs, rather than a zero-sum game
.
Driven by the policy, the launch of new Chinese medicines has been significantly accelerated, and the reform of Chinese medicine formula granules has accelerated.
With the support of the national medical insurance, the Chinese medicine industry is expected to achieve sustained prosperity in the future
.
.
Driven by the policy, the launch of new Chinese medicines has been significantly accelerated, and the reform of Chinese medicine formula granules has accelerated.
With the support of the national medical insurance, the Chinese medicine industry is expected to achieve sustained prosperity in the future
.
At the turn of the new year, the pharmaceutical industry is on the rise again
.
First, it was reported on the Internet that Chinese pharmaceutical companies were included in the restricted list by the United States, and the road to internationalization was blocked, resulting in a plunge in all sectors related to innovative drugs
.
Subsequently, the domestic test data of a well-known pharmaceutical company was questioned by the FDA, which caused concern in the industry
.
Then, in the craze for oral new crown drug research and development, the results of a clinical phase III clinical trial of a well-known biotech company in China failed to meet expectations, which once again deepened the market's panic about innovative drugs
.
.
First, it was reported on the Internet that Chinese pharmaceutical companies were included in the restricted list by the United States, and the road to internationalization was blocked, resulting in a plunge in all sectors related to innovative drugs
.
Subsequently, the domestic test data of a well-known pharmaceutical company was questioned by the FDA, which caused concern in the industry
.
Then, in the craze for oral new crown drug research and development, the results of a clinical phase III clinical trial of a well-known biotech company in China failed to meet expectations, which once again deepened the market's panic about innovative drugs
.
Funds are looking for safe havens, and the traditional Chinese medicine sector, which has been tepid for many years, has become a fragrant pastry overnight
.
For a time, various brokerages and various media said that Chinese medicine must be said
.
Immediately afterwards, the National Medical Insurance Administration and the Administration of Traditional Chinese Medicine issued the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine" (hereinafter referred to as the "Guiding Opinions")
.
Delighted with such divine assistance, traditional Chinese medicine can be described as "every time, heaven and earth all work together"
.
On January 4, the first trading day of the new year, 20% of A-share Chinese medicine stocks hit the daily limit! However, the traditional Chinese medicine sector was pulled back the next day
.
.
For a time, various brokerages and various media said that Chinese medicine must be said
.
Immediately afterwards, the National Medical Insurance Administration and the Administration of Traditional Chinese Medicine issued the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine" (hereinafter referred to as the "Guiding Opinions")
.
Delighted with such divine assistance, traditional Chinese medicine can be described as "every time, heaven and earth all work together"
.
On January 4, the first trading day of the new year, 20% of A-share Chinese medicine stocks hit the daily limit! However, the traditional Chinese medicine sector was pulled back the next day
.
Mr.
Piao once said that "business management can't stare at the stock price every day", so how should traditional Chinese medicine be developed as a traditional cultural treasure of the motherland? In recent years, the state has issued many policies in the field of traditional Chinese medicine, and continued to increase support and investment, which contains thinking and guidance on the future development path of traditional Chinese medicine
.
Piao once said that "business management can't stare at the stock price every day", so how should traditional Chinese medicine be developed as a traditional cultural treasure of the motherland? In recent years, the state has issued many policies in the field of traditional Chinese medicine, and continued to increase support and investment, which contains thinking and guidance on the future development path of traditional Chinese medicine
.
Figure 1.
Major policies of the Chinese medicine industry in recent years
Major policies of the Chinese medicine industry in recent years
Source: Government website, Zhongkang Industrial Capital Research Center
Strengthen medical insurance support
On December 30, 2021, the "Guiding Opinions" jointly issued by the National Medical Insurance Administration and the Administration of Traditional Chinese Medicine promoted the reform of traditional Chinese medicine from the aspects of terminal coverage, pricing system, and payment system
.
Previously, some policies started from the top-level design, which was a little rhetorical but unrealistic, and this document has unprecedented benefits for the implementation of traditional Chinese medicine
.
.
Previously, some policies started from the top-level design, which was a little rhetorical but unrealistic, and this document has unprecedented benefits for the implementation of traditional Chinese medicine
.
Figure 2.
Core content of the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine"
Core content of the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine"
Source: State Administration of Traditional Chinese Medicine website, Zhongkang Industrial Capital Research Center
From the core content of the "Guiding Opinions", it can be seen that traditional Chinese medicine medical services benefit the most from it.
The positive factors include: the inclusion of more terminals in medical insurance; the dynamic adjustment of prices makes the service possible to increase the price; the 25% markup of decoction pieces is reserved, and the decoction pieces in the hospital and The independent pricing of preparations and the transparency of the price of formula granules have a positive impact on the drug revenue of traditional Chinese medicine services; it is clear that the temporary absence of DRG payment can increase the amount of traditional Chinese medicine prescriptions
.
This results relative to the zero addition, the implementation of DRG payment of generics and innovative drugs, medical institutions is clearly more popular with a good variety of traditional Chinese medicine, traditional Chinese medicine prescriptions for enhancing the use of scenarios under medical institutions and some OTC sale of Chinese medicine has a certain significance
.
The positive factors include: the inclusion of more terminals in medical insurance; the dynamic adjustment of prices makes the service possible to increase the price; the 25% markup of decoction pieces is reserved, and the decoction pieces in the hospital and The independent pricing of preparations and the transparency of the price of formula granules have a positive impact on the drug revenue of traditional Chinese medicine services; it is clear that the temporary absence of DRG payment can increase the amount of traditional Chinese medicine prescriptions
.
This results relative to the zero addition, the implementation of DRG payment of generics and innovative drugs, medical institutions is clearly more popular with a good variety of traditional Chinese medicine, traditional Chinese medicine prescriptions for enhancing the use of scenarios under medical institutions and some OTC sale of Chinese medicine has a certain significance
.
The "Guiding Opinions" encourages the inclusion of traditional Chinese medicine formula granules purchased by public medical institutions into provincial-level centralized pharmaceutical procurement platforms for online transactions to promote open and transparent transactions
.
The gradual standardization of the national market medical insurance payment standard for formula granules will break the exclusive advantage of medical insurance reimbursement of provincial pilot enterprises under local protection , which is conducive to the orderly development of the market
.
In February 2022, the State Food and Drug Administration and other four departments jointly issued the "Announcement on Ending the Pilot Work of TCM Formula Granules", and the switching of implementation standards in the future will bring opportunities for the price increase of TCM formula granules
.
In addition, after the implementation of the new national standard, there may be a nationwide centralized procurement, which will increase the substitution rate of formula granules for decoction pieces, and the exchange of price for quantity is expected to bring growth to related enterprises
.
.
The gradual standardization of the national market medical insurance payment standard for formula granules will break the exclusive advantage of medical insurance reimbursement of provincial pilot enterprises under local protection , which is conducive to the orderly development of the market
.
In February 2022, the State Food and Drug Administration and other four departments jointly issued the "Announcement on Ending the Pilot Work of TCM Formula Granules", and the switching of implementation standards in the future will bring opportunities for the price increase of TCM formula granules
.
In addition, after the implementation of the new national standard, there may be a nationwide centralized procurement, which will increase the substitution rate of formula granules for decoction pieces, and the exchange of price for quantity is expected to bring growth to related enterprises
.
Accelerate Chinese Medicine Development Features
On February 9, 2021, the General Office of the State Council issued the "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Characteristics" (hereinafter referred to as "Policy Measures"), which aims to give full play to the characteristics and comparative advantages of traditional Chinese medicine and promote the mutual complementation of traditional Chinese medicine and Western medicine.
, Coordinated development
.
This document includes 28 policies and measures, covering 7 major aspects: consolidate the talent base of traditional Chinese medicine, improve the development vitality of the traditional Chinese medicine industry, enhance the development momentum of traditional Chinese medicine, improve the system of integrated traditional Chinese and western medicine, implement major projects for the development of traditional Chinese medicine, improve the development efficiency of traditional Chinese medicine, Create a favorable environment for the development of traditional Chinese medicine
.
, Coordinated development
.
This document includes 28 policies and measures, covering 7 major aspects: consolidate the talent base of traditional Chinese medicine, improve the development vitality of the traditional Chinese medicine industry, enhance the development momentum of traditional Chinese medicine, improve the system of integrated traditional Chinese and western medicine, implement major projects for the development of traditional Chinese medicine, improve the development efficiency of traditional Chinese medicine, Create a favorable environment for the development of traditional Chinese medicine
.
Figure 3.
Main content of "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Characteristics"
Main content of "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Characteristics"
Source: National government website, Zhongkang Industrial Capital Research Center
In terms of promoting the high-quality development of the traditional Chinese medicine industry, the first is to optimize the management of the review and approval of traditional Chinese medicines, and the second is to improve the management of the classification and registration of traditional Chinese medicines
.
The "Policy Measures" pointed out that it is necessary to strengthen the horizontal linkage of departments, and establish an effective mechanism for the departments of science and technology, medical care, and traditional Chinese medicine to recommend new traditional Chinese medicines to enter the fast-track review and approval channel
.
The document also points out that it is necessary to improve the registration classification and application requirements of traditional Chinese medicine, and exempt non-clinical safety research and some clinical trials for eligible innovative traditional Chinese medicine drugs, new improved traditional Chinese medicine drugs, ancient classic prescriptions, and drugs with the same name and same name
.
Make full use of data science and other technical means to establish a "three-in-one" Chinese medicine registration review evidence system of traditional Chinese medicine theory, human experience, and clinical trials, and explore the establishment of a real-world research evidence system for traditional Chinese medicine
.
.
The "Policy Measures" pointed out that it is necessary to strengthen the horizontal linkage of departments, and establish an effective mechanism for the departments of science and technology, medical care, and traditional Chinese medicine to recommend new traditional Chinese medicines to enter the fast-track review and approval channel
.
The document also points out that it is necessary to improve the registration classification and application requirements of traditional Chinese medicine, and exempt non-clinical safety research and some clinical trials for eligible innovative traditional Chinese medicine drugs, new improved traditional Chinese medicine drugs, ancient classic prescriptions, and drugs with the same name and same name
.
Make full use of data science and other technical means to establish a "three-in-one" Chinese medicine registration review evidence system of traditional Chinese medicine theory, human experience, and clinical trials, and explore the establishment of a real-world research evidence system for traditional Chinese medicine
.
The "Policy Measures" further accelerated the review and approval of new Chinese medicines.
From 2017 to 2021, a total of 20 new Chinese medicines were approved for marketing, of which as many as 12 in 2021
.
From the perspective of therapeutic areas, there are many drugs related to endocrine system and metabolic diseases, circulatory system diseases, musculoskeletal system diseases, and respiratory system diseases
.
New traditional Chinese medicine drugs can be included in the national medical insurance through normalized negotiation, and the volume can be quickly realized
.
Judging from the price drop of new drugs in the medical insurance negotiation in 2020, the average price drop of Chinese patent medicines is 37%, which is smaller than the average drop of 63% for western medicines
.
From 2017 to 2021, a total of 20 new Chinese medicines were approved for marketing, of which as many as 12 in 2021
.
From the perspective of therapeutic areas, there are many drugs related to endocrine system and metabolic diseases, circulatory system diseases, musculoskeletal system diseases, and respiratory system diseases
.
New traditional Chinese medicine drugs can be included in the national medical insurance through normalized negotiation, and the volume can be quickly realized
.
Judging from the price drop of new drugs in the medical insurance negotiation in 2020, the average price drop of Chinese patent medicines is 37%, which is smaller than the average drop of 63% for western medicines
.
Figure 4.
New Chinese medicines approved for marketing in China in 2021
New Chinese medicines approved for marketing in China in 2021
Source: State Food and Drug Administration, Zhongkang Industrial Capital Research Center
Chinese medicine industry is expected to continue to prosper
Compared with Western medicine, traditional Chinese medicine has unique advantages in specific therapeutic areas, and it is mainly complementary and synergistic development with innovative drugs and generic drugs, rather than a zero-sum game
.
Driven by the policy, the launch of new Chinese medicines has been significantly accelerated, and the reform of Chinese medicine formula granules has accelerated.
With the support of the national medical insurance, the Chinese medicine industry is expected to achieve sustained prosperity in the future
.
.
Driven by the policy, the launch of new Chinese medicines has been significantly accelerated, and the reform of Chinese medicine formula granules has accelerated.
With the support of the national medical insurance, the Chinese medicine industry is expected to achieve sustained prosperity in the future
.
At the turn of the new year, the pharmaceutical industry is on the rise again
.
First, it was reported on the Internet that Chinese pharmaceutical companies were included in the restricted list by the United States, and the road to internationalization was blocked, resulting in a plunge in all sectors related to innovative drugs
.
Subsequently, the domestic test data of a well-known pharmaceutical company was questioned by the FDA, which caused concern in the industry
.
Then, in the craze for oral new crown drug research and development, the results of a clinical phase III clinical trial of a well-known biotech company in China failed to meet expectations, which once again deepened the market's panic about innovative drugs
.
.
First, it was reported on the Internet that Chinese pharmaceutical companies were included in the restricted list by the United States, and the road to internationalization was blocked, resulting in a plunge in all sectors related to innovative drugs
.
Subsequently, the domestic test data of a well-known pharmaceutical company was questioned by the FDA, which caused concern in the industry
.
Then, in the craze for oral new crown drug research and development, the results of a clinical phase III clinical trial of a well-known biotech company in China failed to meet expectations, which once again deepened the market's panic about innovative drugs
.
Funds are looking for safe havens, and the traditional Chinese medicine sector, which has been tepid for many years, has become a fragrant pastry overnight
.
For a time, various brokerages and various media said that Chinese medicine must be said
.
Immediately afterwards, the National Medical Insurance Administration and the Administration of Traditional Chinese Medicine issued the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine" (hereinafter referred to as the "Guiding Opinions")
.
Delighted with such divine assistance, traditional Chinese medicine can be described as "every time, heaven and earth all work together"
.
On January 4, the first trading day of the new year, 20% of A-share Chinese medicine stocks hit the daily limit! However, the traditional Chinese medicine sector was pulled back the next day
.
medicine medicine medicine.
For a time, various brokerages and various media said that Chinese medicine must be said
.
Immediately afterwards, the National Medical Insurance Administration and the Administration of Traditional Chinese Medicine issued the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine" (hereinafter referred to as the "Guiding Opinions")
.
Delighted with such divine assistance, traditional Chinese medicine can be described as "every time, heaven and earth all work together"
.
On January 4, the first trading day of the new year, 20% of A-share Chinese medicine stocks hit the daily limit! However, the traditional Chinese medicine sector was pulled back the next day
.
Mr.
Piao once said that "business management can't stare at the stock price every day", so how should traditional Chinese medicine be developed as a traditional cultural treasure of the motherland? In recent years, the state has issued many policies in the field of traditional Chinese medicine, and continued to increase support and investment, which contains thinking and guidance on the future development path of traditional Chinese medicine
.
Piao once said that "business management can't stare at the stock price every day", so how should traditional Chinese medicine be developed as a traditional cultural treasure of the motherland? In recent years, the state has issued many policies in the field of traditional Chinese medicine, and continued to increase support and investment, which contains thinking and guidance on the future development path of traditional Chinese medicine
.
Figure 1.
Major policies of the Chinese medicine industry in recent years
Major policies of the Chinese medicine industry in recent years
Source: Government website, Zhongkang Industrial Capital Research Center
Strengthen medical insurance support
Strengthen medical insurance support On December 30, 2021, the "Guiding Opinions" jointly issued by the National Medical Insurance Administration and the Administration of Traditional Chinese Medicine promoted the reform of traditional Chinese medicine from the aspects of terminal coverage, pricing system, and payment system
.
Previously, some policies started from the top-level design, which was a little rhetorical but unrealistic, and this document has unprecedented benefits for the implementation of traditional Chinese medicine
.
.
Previously, some policies started from the top-level design, which was a little rhetorical but unrealistic, and this document has unprecedented benefits for the implementation of traditional Chinese medicine
.
Figure 2.
Core content of the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine"
Core content of the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine"
Source: State Administration of Traditional Chinese Medicine website, Zhongkang Industrial Capital Research Center
From the core content of the "Guiding Opinions", it can be seen that traditional Chinese medicine medical services benefit the most from it.
The positive factors include: the inclusion of more terminals in medical insurance; the dynamic adjustment of prices makes the service possible to increase the price; the 25% markup of decoction pieces is reserved, and the decoction pieces in the hospital and The independent pricing of preparations and the transparency of the price of formula granules have a positive impact on the drug revenue of traditional Chinese medicine services; it is clear that the temporary absence of DRG payment can increase the amount of traditional Chinese medicine prescriptions
.
This results relative to the zero addition, the implementation of DRG payment of generics and innovative drugs, medical institutions is clearly more popular with a good variety of traditional Chinese medicine, traditional Chinese medicine prescriptions for enhancing the use of scenarios under medical institutions and some OTC sale of Chinese medicine has a certain significance
.
OTC OTCThe positive factors include: the inclusion of more terminals in medical insurance; the dynamic adjustment of prices makes the service possible to increase the price; the 25% markup of decoction pieces is reserved, and the decoction pieces in the hospital and The independent pricing of preparations and the transparency of the price of formula granules have a positive impact on the drug revenue of traditional Chinese medicine services; it is clear that the temporary absence of DRG payment can increase the amount of traditional Chinese medicine prescriptions
.
This results relative to the zero addition, the implementation of DRG payment of generics and innovative drugs, medical institutions is clearly more popular with a good variety of traditional Chinese medicine, traditional Chinese medicine prescriptions for enhancing the use of scenarios under medical institutions and some OTC sale of Chinese medicine has a certain significance
.
The "Guiding Opinions" encourages the inclusion of traditional Chinese medicine formula granules purchased by public medical institutions into provincial-level centralized pharmaceutical procurement platforms for online transactions to promote open and transparent transactions
.
The gradual standardization of the national market medical insurance payment standard for formula granules will break the exclusive advantage of medical insurance reimbursement of provincial pilot enterprises under local protection , which is conducive to the orderly development of the market
.
In February 2022, the State Food and Drug Administration and other four departments jointly issued the "Announcement on Ending the Pilot Work of TCM Formula Granules", and the switching of implementation standards in the future will bring opportunities for the price increase of TCM formula granules
.
In addition, after the implementation of the new national standard, there may be a nationwide centralized procurement, which will increase the substitution rate of formula granules for decoction pieces, and the exchange of price for quantity is expected to bring growth to related enterprises
.
enterprise enterprise enterprise.
The gradual standardization of the national market medical insurance payment standard for formula granules will break the exclusive advantage of medical insurance reimbursement of provincial pilot enterprises under local protection , which is conducive to the orderly development of the market
.
In February 2022, the State Food and Drug Administration and other four departments jointly issued the "Announcement on Ending the Pilot Work of TCM Formula Granules", and the switching of implementation standards in the future will bring opportunities for the price increase of TCM formula granules
.
In addition, after the implementation of the new national standard, there may be a nationwide centralized procurement, which will increase the substitution rate of formula granules for decoction pieces, and the exchange of price for quantity is expected to bring growth to related enterprises
.
Accelerate Chinese Medicine Development Features
Speed up Chinese medicine Chinese medicine Chinese medicine development characteristics On February 9, 2021, the General Office of the State Council issued the "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Characteristics" (hereinafter referred to as "Policy Measures"), which aims to give full play to the characteristics and comparative advantages of traditional Chinese medicine and promote the mutual complementation of traditional Chinese medicine and Western medicine.
, Coordinated development
.
This document includes 28 policies and measures, covering 7 major aspects: consolidate the talent base of traditional Chinese medicine, improve the development vitality of the traditional Chinese medicine industry, enhance the development momentum of traditional Chinese medicine, improve the system of integrated traditional Chinese and western medicine, implement major projects for the development of traditional Chinese medicine, improve the development efficiency of traditional Chinese medicine, Create a favorable environment for the development of traditional Chinese medicine
.
, Coordinated development
.
This document includes 28 policies and measures, covering 7 major aspects: consolidate the talent base of traditional Chinese medicine, improve the development vitality of the traditional Chinese medicine industry, enhance the development momentum of traditional Chinese medicine, improve the system of integrated traditional Chinese and western medicine, implement major projects for the development of traditional Chinese medicine, improve the development efficiency of traditional Chinese medicine, Create a favorable environment for the development of traditional Chinese medicine
.
Figure 3.
Main content of "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Characteristics"
Main content of "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Characteristics"
Source: National government website, Zhongkang Industrial Capital Research Center
In terms of promoting the high-quality development of the traditional Chinese medicine industry, the first is to optimize the management of the review and approval of traditional Chinese medicines, and the second is to improve the management of the classification and registration of traditional Chinese medicines
.
The "Policy Measures" pointed out that it is necessary to strengthen the horizontal linkage of departments, and establish an effective mechanism for the departments of science and technology, medical care, and traditional Chinese medicine to recommend new traditional Chinese medicines to enter the fast-track review and approval channel
.
The document also points out that it is necessary to improve the registration classification and application requirements of traditional Chinese medicine, and exempt non-clinical safety research and some clinical trials for eligible innovative traditional Chinese medicine drugs, new improved traditional Chinese medicine drugs, ancient classic prescriptions, and drugs with the same name and same name
.
Make full use of data science and other technical means to establish a "three-in-one" Chinese medicine registration review evidence system of traditional Chinese medicine theory, human experience, and clinical trials, and explore the establishment of a real-world research evidence system for traditional Chinese medicine
.
.
The "Policy Measures" pointed out that it is necessary to strengthen the horizontal linkage of departments, and establish an effective mechanism for the departments of science and technology, medical care, and traditional Chinese medicine to recommend new traditional Chinese medicines to enter the fast-track review and approval channel
.
The document also points out that it is necessary to improve the registration classification and application requirements of traditional Chinese medicine, and exempt non-clinical safety research and some clinical trials for eligible innovative traditional Chinese medicine drugs, new improved traditional Chinese medicine drugs, ancient classic prescriptions, and drugs with the same name and same name
.
Make full use of data science and other technical means to establish a "three-in-one" Chinese medicine registration review evidence system of traditional Chinese medicine theory, human experience, and clinical trials, and explore the establishment of a real-world research evidence system for traditional Chinese medicine
.
The "Policy Measures" further accelerated the review and approval of new Chinese medicines.
From 2017 to 2021, a total of 20 new Chinese medicines were approved for marketing, of which as many as 12 in 2021
.
From the perspective of therapeutic areas, there are many drugs related to endocrine system and metabolic diseases, circulatory system diseases, musculoskeletal system diseases, and respiratory system diseases
.
New traditional Chinese medicine drugs can be included in the national medical insurance through normalized negotiation, and the volume can be quickly realized
.
Judging from the price drop of new drugs in the medical insurance negotiation in 2020, the average price drop of Chinese patent medicines is 37%, which is smaller than the average drop of 63% for western medicines
.
medicines medicines medicinesFrom 2017 to 2021, a total of 20 new Chinese medicines were approved for marketing, of which as many as 12 in 2021
.
From the perspective of therapeutic areas, there are many drugs related to endocrine system and metabolic diseases, circulatory system diseases, musculoskeletal system diseases, and respiratory system diseases
.
New traditional Chinese medicine drugs can be included in the national medical insurance through normalized negotiation, and the volume can be quickly realized
.
Judging from the price drop of new drugs in the medical insurance negotiation in 2020, the average price drop of Chinese patent medicines is 37%, which is smaller than the average drop of 63% for western medicines
.
Figure 4.
New Chinese medicines approved for marketing in China in 2021
New Chinese medicines approved for marketing in China in 2021
Source: State Food and Drug Administration, Zhongkang Industrial Capital Research Center
Chinese medicine industry is expected to continue to prosper
Chinese medicine industry is expected to continue to prosper Compared with Western medicine, traditional Chinese medicine has unique advantages in specific therapeutic areas, and it is mainly complementary and synergistic development with innovative drugs and generic drugs, rather than a zero-sum game
.
Driven by the policy, the launch of new Chinese medicines has been significantly accelerated, and the reform of Chinese medicine formula granules has accelerated.
With the support of the national medical insurance, the Chinese medicine industry is expected to achieve sustained prosperity in the future
.
.
Driven by the policy, the launch of new Chinese medicines has been significantly accelerated, and the reform of Chinese medicine formula granules has accelerated.
With the support of the national medical insurance, the Chinese medicine industry is expected to achieve sustained prosperity in the future
.
